Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Molecular Pathology, |
RCV000755658 | SCV002761519 | likely pathogenic | Infantile liver failure syndrome 2 | 2021-05-18 | criteria provided, single submitter | clinical testing | The NBAS c.1501C>T variant is a single nucleotide change which is predicted to result in premature termination of the protein product at codon 501 (PVS1). This variant has been identified in a patient with short stature, hypogammaglobinaemia, ocular involvement, and elevated liver transaminases (PMID:30825388) (PS4_mod). This variant is in dbSNP (rs759960319) but is rare in population databases (gnomAD 4/251424, 0 homozygotes). This variant has been reported in ClinVar as pathogenic for Infantile liver failure syndrome 2 by another diagnostic laboratory (ClinVar Variation ID: 609275). The NBAS c.1501C>T variant is classified as LIKELY PATHOGENIC (PS4_mod, PVS1) |
Labcorp Genetics |
RCV003117538 | SCV003786370 | pathogenic | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg501*) in the NBAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBAS are known to be pathogenic (PMID: 26073778, 26541327, 27789416, 28031453). This variant is present in population databases (rs759960319, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with NBAS-related conditions (PMID: 30825388). ClinVar contains an entry for this variant (Variation ID: 617878). For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Medical Genetics, |
RCV000755658 | SCV000882687 | pathogenic | Infantile liver failure syndrome 2 | 2018-11-07 | no assertion criteria provided | clinical testing | Found in compound heterozygosity with c.6840G>A |